Similar Items: Targeting the EBFR and PI3K pathways as a therapeutic strategy for prostate cancer
- Retrospective review: diagnostic performance of PI-RADS V2.1 4 and 5 lesions in predicting clinically significant prostate cancer at Groote Schuur Hospital, South Africa
- Radiosensitisation of androgen-dependent and independent tumour cells as a therapeutic strategy in prostate cancer
- A study of the endocrine control of the prostate gland in relation to the etiology and the treatment of prostatic carcinoma and benign prostatic hyperplasia
- Comparative secretome analysis of normal prostate and prostate cancer cell models
- The role of stroma on normal, hyperplastic and neoplastic prostatic growth, with emphasis on prostatic glycosaminoglycans
- Cell-free DNA and tumor exosome cargo as diagnostic and prognostic marker for prostate cancer